Cargando…

Clinical utility of complex assessment with evoked potentials in acute lymphoblastic leukemia survivors: comparison of various treatment protocols

BACKGROUND: One of the greatest success of pediatric hematology is a prominent improvement of survival in acute lymphoblastic leukemia (ALL). Therefore, special attention needs to be paid to long-term side effects of the treatment such as neurotoxicity. One of the few diagnostic methods that allow a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kroczka, Slawomir, Stepien, Konrad, Witek-Motyl, Izabela, Kwiecinska, Kinga, Kapusta, Eryk, Biedron, Agnieszka, Skorek, Pawel, Skoczen, Szymon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876796/
https://www.ncbi.nlm.nih.gov/pubmed/33568096
http://dx.doi.org/10.1186/s12885-021-07873-x
_version_ 1783650039612047360
author Kroczka, Slawomir
Stepien, Konrad
Witek-Motyl, Izabela
Kwiecinska, Kinga
Kapusta, Eryk
Biedron, Agnieszka
Skorek, Pawel
Skoczen, Szymon
author_facet Kroczka, Slawomir
Stepien, Konrad
Witek-Motyl, Izabela
Kwiecinska, Kinga
Kapusta, Eryk
Biedron, Agnieszka
Skorek, Pawel
Skoczen, Szymon
author_sort Kroczka, Slawomir
collection PubMed
description BACKGROUND: One of the greatest success of pediatric hematology is a prominent improvement of survival in acute lymphoblastic leukemia (ALL). Therefore, special attention needs to be paid to long-term side effects of the treatment such as neurotoxicity. One of the few diagnostic methods that allow an objective assessment of sensory systems are evoked potentials (EP). METHODS: The analyzed group consisted of 167 ALL long-term survivors, aged 4.9–28.4 years, without auditory, visual and sensory deviations. Patients were treated with New York (NY, n = 35), previous modified Berlin-Frankfurt-Münster (pBFM, n = 47) and BFM95 (n = 85) protocols. In order to assess the impact of radiotherapy on recorded EP, a joint analysis of NY and pBFM groups was performed. The control group consisted of 35 patients, aged 6–17 years. The analyzed patients underwent a complex assessment with visual EP (VEP), somatosensory EP (SEP) and brainstem auditory EP (BAEP) in accordance with current standards. RESULTS: ALL treatment contributed to the shortening of wave I latency (1.59 vs 1.90, P = 0.003) and prolongation of I-III (2.23 vs 2.04, P = 0.004) and I-V (4.57 vs 4.24, P = 0.002) interwave latencies of BAEP. A significant effect was also noticed in P100 (106.32 vs 101.57, P < 0.001) and N135 (151.42 vs 138.22, P < 0.001) latencies of VEP and N18 amplitude (3.24 vs 4.70, P = 0.007) and P25 latency (21.32 vs 23.39, P < 0.001) of SEP. The distribution of abnormalities between protocols was similar in BAEP (NY - 68.6%, pBFM - 61.7%, BFM95–69.4%, P = 0.650), VEP (NY - 68.6%, pBFM - 42.5%, BFM95–58.3%, P = 0.053) and significantly different for SEP (NY - 62.9%, pBFM - 36.2%, BFM95–53.0%, P = 0.045). The harmful effect of radiotherapy was most clearly marked in numerous disturbances of SEP parameters. CONCLUSIONS: The presented analysis indicates a high frequency of subclinical abnormalities in EP regardless of the analyzed protocol. To our knowledge current study is the largest and one of the most complex research examining the role of EP in ALL patients. The obtained results indicate the possibility of using a single, objective and non-invasive measurement of EP in ALL survivors in order to stratify the risk of developing sensory abnormalities in adulthood.
format Online
Article
Text
id pubmed-7876796
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78767962021-02-11 Clinical utility of complex assessment with evoked potentials in acute lymphoblastic leukemia survivors: comparison of various treatment protocols Kroczka, Slawomir Stepien, Konrad Witek-Motyl, Izabela Kwiecinska, Kinga Kapusta, Eryk Biedron, Agnieszka Skorek, Pawel Skoczen, Szymon BMC Cancer Research Article BACKGROUND: One of the greatest success of pediatric hematology is a prominent improvement of survival in acute lymphoblastic leukemia (ALL). Therefore, special attention needs to be paid to long-term side effects of the treatment such as neurotoxicity. One of the few diagnostic methods that allow an objective assessment of sensory systems are evoked potentials (EP). METHODS: The analyzed group consisted of 167 ALL long-term survivors, aged 4.9–28.4 years, without auditory, visual and sensory deviations. Patients were treated with New York (NY, n = 35), previous modified Berlin-Frankfurt-Münster (pBFM, n = 47) and BFM95 (n = 85) protocols. In order to assess the impact of radiotherapy on recorded EP, a joint analysis of NY and pBFM groups was performed. The control group consisted of 35 patients, aged 6–17 years. The analyzed patients underwent a complex assessment with visual EP (VEP), somatosensory EP (SEP) and brainstem auditory EP (BAEP) in accordance with current standards. RESULTS: ALL treatment contributed to the shortening of wave I latency (1.59 vs 1.90, P = 0.003) and prolongation of I-III (2.23 vs 2.04, P = 0.004) and I-V (4.57 vs 4.24, P = 0.002) interwave latencies of BAEP. A significant effect was also noticed in P100 (106.32 vs 101.57, P < 0.001) and N135 (151.42 vs 138.22, P < 0.001) latencies of VEP and N18 amplitude (3.24 vs 4.70, P = 0.007) and P25 latency (21.32 vs 23.39, P < 0.001) of SEP. The distribution of abnormalities between protocols was similar in BAEP (NY - 68.6%, pBFM - 61.7%, BFM95–69.4%, P = 0.650), VEP (NY - 68.6%, pBFM - 42.5%, BFM95–58.3%, P = 0.053) and significantly different for SEP (NY - 62.9%, pBFM - 36.2%, BFM95–53.0%, P = 0.045). The harmful effect of radiotherapy was most clearly marked in numerous disturbances of SEP parameters. CONCLUSIONS: The presented analysis indicates a high frequency of subclinical abnormalities in EP regardless of the analyzed protocol. To our knowledge current study is the largest and one of the most complex research examining the role of EP in ALL patients. The obtained results indicate the possibility of using a single, objective and non-invasive measurement of EP in ALL survivors in order to stratify the risk of developing sensory abnormalities in adulthood. BioMed Central 2021-02-10 /pmc/articles/PMC7876796/ /pubmed/33568096 http://dx.doi.org/10.1186/s12885-021-07873-x Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Kroczka, Slawomir
Stepien, Konrad
Witek-Motyl, Izabela
Kwiecinska, Kinga
Kapusta, Eryk
Biedron, Agnieszka
Skorek, Pawel
Skoczen, Szymon
Clinical utility of complex assessment with evoked potentials in acute lymphoblastic leukemia survivors: comparison of various treatment protocols
title Clinical utility of complex assessment with evoked potentials in acute lymphoblastic leukemia survivors: comparison of various treatment protocols
title_full Clinical utility of complex assessment with evoked potentials in acute lymphoblastic leukemia survivors: comparison of various treatment protocols
title_fullStr Clinical utility of complex assessment with evoked potentials in acute lymphoblastic leukemia survivors: comparison of various treatment protocols
title_full_unstemmed Clinical utility of complex assessment with evoked potentials in acute lymphoblastic leukemia survivors: comparison of various treatment protocols
title_short Clinical utility of complex assessment with evoked potentials in acute lymphoblastic leukemia survivors: comparison of various treatment protocols
title_sort clinical utility of complex assessment with evoked potentials in acute lymphoblastic leukemia survivors: comparison of various treatment protocols
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876796/
https://www.ncbi.nlm.nih.gov/pubmed/33568096
http://dx.doi.org/10.1186/s12885-021-07873-x
work_keys_str_mv AT kroczkaslawomir clinicalutilityofcomplexassessmentwithevokedpotentialsinacutelymphoblasticleukemiasurvivorscomparisonofvarioustreatmentprotocols
AT stepienkonrad clinicalutilityofcomplexassessmentwithevokedpotentialsinacutelymphoblasticleukemiasurvivorscomparisonofvarioustreatmentprotocols
AT witekmotylizabela clinicalutilityofcomplexassessmentwithevokedpotentialsinacutelymphoblasticleukemiasurvivorscomparisonofvarioustreatmentprotocols
AT kwiecinskakinga clinicalutilityofcomplexassessmentwithevokedpotentialsinacutelymphoblasticleukemiasurvivorscomparisonofvarioustreatmentprotocols
AT kapustaeryk clinicalutilityofcomplexassessmentwithevokedpotentialsinacutelymphoblasticleukemiasurvivorscomparisonofvarioustreatmentprotocols
AT biedronagnieszka clinicalutilityofcomplexassessmentwithevokedpotentialsinacutelymphoblasticleukemiasurvivorscomparisonofvarioustreatmentprotocols
AT skorekpawel clinicalutilityofcomplexassessmentwithevokedpotentialsinacutelymphoblasticleukemiasurvivorscomparisonofvarioustreatmentprotocols
AT skoczenszymon clinicalutilityofcomplexassessmentwithevokedpotentialsinacutelymphoblasticleukemiasurvivorscomparisonofvarioustreatmentprotocols